首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Application of the equivalence test for analytical method transfers: testing precision using the United States Pharmacopoeia concept (1010).
【24h】

Application of the equivalence test for analytical method transfers: testing precision using the United States Pharmacopoeia concept (1010).

机译:当量检验在分析方法转移中的应用:使用美国药典概念(1010)进行检验精度。

获取原文
获取原文并翻译 | 示例
           

摘要

In this work, the performance of the USP (1010) concept for comparing precision has been investigated. A diagram has been constructed to relate common variance ratios, sample sizes and the corresponding powers. The choice of the upper acceptable limit of variance ratios strongly influences the power. Small upper limits, such as 2.25, are not practical. The proposed upper limit of 4 requires sample sizes of 14 or higher to achieve a power of 80%. If the precision of a method is very good, higher ratios seem to be acceptable, with a significant reduction in measurements. For example, using n = 6 is sufficient to obtain a power of 90%, if the variances are in fact the same and the acceptable variance ratio is 16.
机译:在这项工作中,已经研究了USP(1010)概念用于比较精度的性能。已构建了一个图,用于关联常见方差比,样本大小和相应功效。方差比的可接受上限的选择强烈影响功率。较小的上限(例如2.25)不切实际。建议的上限4需要14个或更大的样本大小才能达到80%的功效。如果方法的精度非常好,那么更高的比率似乎是可以接受的,并且测量值会大大减少。例如,如果方差实际上相同并且可接受的方差比为16,则使用n = 6足以获得90%的功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号